Antifibrotic Activity Of GI262570 In Chronic Hepatitis C Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

265

Participants

Timeline

Start Date

November 2, 2005

Primary Completion Date

March 13, 2008

Study Completion Date

March 13, 2008

Conditions
Cirrhosis, Liver
Interventions
DRUG

GI262570 0.5 mg

GI262570 0.5 mg

DRUG

GI262570 1.0 mg

GI262570 1.0 mg

DRUG

Placebo

Placebo

Trial Locations (121)

112

GSK Investigational Site, Taipei

333

GSK Investigational Site, Taoyuan District

833

GSK Investigational Site, Kaohsiung City

1001

GSK Investigational Site, Auckland

3004

GSK Investigational Site, Melbourne

3065

GSK Investigational Site, Fitzroy, Melbourne

3084

GSK Investigational Site, Heidelberg

3168

GSK Investigational Site, Clayton

4029

GSK Investigational Site, Herston

10003

GSK Investigational Site, New York

10021

GSK Investigational Site, New York

10029

GSK Investigational Site, New York

10032

GSK Investigational Site, New York

10468

GSK Investigational Site, The Bronx

11030

GSK Investigational Site, Manhasset

13210

GSK Investigational Site, Syracuse

13353

GSK Investigational Site, Berlin

13901

GSK Investigational Site, Binghamton

16100

GSK Investigational Site, Nazareth

20010

GSK Investigational Site, Washington D.C.

20246

GSK Investigational Site, Hamburg

21093

GSK Investigational Site, Lutherville-Timonium

22031

GSK Investigational Site, Fairfax

22908

GSK Investigational Site, Charlottesville

23249

GSK Investigational Site, Richmond

23298

GSK Investigational Site, Richmond

27599

GSK Investigational Site, Chapel Hill

27710

GSK Investigational Site, Durham

30033

GSK Investigational Site, Atlanta

30060

GSK Investigational Site, Marietta

30308

GSK Investigational Site, Atlanta

30309

GSK Investigational Site, Atlanta

30625

GSK Investigational Site, Hanover

31096

GSK Investigational Site, Haifa

32804

GSK Investigational Site, Orlando

33136

GSK Investigational Site, Miami

33308

GSK Investigational Site, Fort Lauderdale

34243

GSK Investigational Site, Sarasota

40202

GSK Investigational Site, Louisville

40225

GSK Investigational Site, Düsseldorf

44195

GSK Investigational Site, Cleveland

45219

GSK Investigational Site, Cincinnati

46202

GSK Investigational Site, Indianapolis

48109

GSK Investigational Site, Ann Arbor

48149

GSK Investigational Site, Münster

48202

GSK Investigational Site, Detroit

49100

GSK Investigational Site, Petah Tikva

52242

GSK Investigational Site, Iowa City

53127

GSK Investigational Site, Bonn

59100

GSK Investigational Site, Bandar Tun Razak, Cheras

60590

GSK Investigational Site, Frankfurt am Main

63104

GSK Investigational Site, St Louis

64239

GSK Investigational Site, Tel Aviv

66421

GSK Investigational Site, Homburg

68100

GSK Investigational Site, Kepong

69120

GSK Investigational Site, Heidelberg

72076

GSK Investigational Site, Tübingen

72117

GSK Investigational Site, North Little Rock

74104

GSK Investigational Site, Tulsa

76100

GSK Investigational Site, Rehovot

77030

GSK Investigational Site, Houston

78215

GSK Investigational Site, San Antonio

79106

GSK Investigational Site, Freiburg im Breisgau

80113

GSK Investigational Site, Englewood

80708

GSK Investigational Site, Kaohsiung City

85719

GSK Investigational Site, Tucson

90048

GSK Investigational Site, Los Angeles

90095

GSK Investigational Site, Los Angeles

91054

GSK Investigational Site, Erlangen

91105

GSK Investigational Site, Pasadena

91120

GSK Investigational Site, Jerusalem

92024

GSK Investigational Site, La Jolla

92663

GSK Investigational Site, Newport Beach

92673

GSK Investigational Site, San Clemente

93301

GSK Investigational Site, Bakersfield

94121

GSK Investigational Site, San Francisco

95051

GSK Investigational Site, Santa Clara

95825

GSK Investigational Site, Sacramento

96817

GSK Investigational Site, Honolulu

105229

GSK Investigational Site, Moscow

115516

GSK Investigational Site, Moscow

121170

GSK Investigational Site, Moscow

129110

GSK Investigational Site, Moscow

169608

GSK Investigational Site, Singapore

400162

GSK Investigational Site, Cluj-Napoca, Cluj

35294-0005

GSK Investigational Site, Birmingham

02111

GSK Investigational Site, Boston

02114

GSK Investigational Site, Boston

02215

GSK Investigational Site, Boston

01655

GSK Investigational Site, Worcester

45267-0595

GSK Investigational Site, Cincinnati

17033-0850

GSK Investigational Site, Hershey

17604-3200

GSK Investigational Site, Lancaster

75390-8887

GSK Investigational Site, Dallas

Unknown

GSK Investigational Site, Camperdown

GSK Investigational Site, Saint Petersburg

T2N 4N1

GSK Investigational Site, Calgary

V5Z 1H2

GSK Investigational Site, Vancouver

V8V 3P9

GSK Investigational Site, Victoria

R3E 3P4

GSK Investigational Site, Winnipeg

B3H 2Y9

GSK Investigational Site, Halifax

N6A 5A5

GSK Investigational Site, London

K1H 8L6

GSK Investigational Site, Ottawa

M5G 1X5

GSK Investigational Site, Toronto

M5G 2N2

GSK Investigational Site, Toronto

M5T 2S8

GSK Investigational Site, Toronto

H2X 3J4

GSK Investigational Site, Montreal

625 00

GSK Investigational Site, Brno - Bohunice

500 12

GSK Investigational Site, Hradec Králové

140 21

GSK Investigational Site, Prague

169 02

GSK Investigational Site, Prague

04103

GSK Investigational Site, Leipzig

06120

GSK Investigational Site, Halle

00909-1711

GSK Investigational Site, San Juan

021105

GSK Investigational Site, Bucharest

022328

GSK Investigational Site, Bucharest

700-721

GSK Investigational Site, Daegu

602-739

GSK Investigational Site, Pusan

135-710

GSK Investigational Site, Seoul

138-736

GSK Investigational Site, Seoul

150-713

GSK Investigational Site, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY